Medical and Pharmaceutical

The company has gained strong market traction by launching over 30 diagnostic products across multiple health categories

The company projects 2025 revenue to range between USD$73 million and USD$85 million

Him and his team have C$1.7M at their disposal for the next few years to find out

The lawsuit exposes and brings closer scrutiny to “potentially anticompetitive” tactics by original equipment manufacturers

When 23andMe collapsed financially, its genetic data quickly attracted attention as a lucrative asset

The model uses graph neural networks to interpret complex biological interactions

The Alberta Cancer Foundation is also contributing C$500K

Researchers are working to bring this technology to market

It will be worth over US$1.3 billion more than its current valuation by 2029, The Business Research Company says

Regulation crowdfunding allows a startup or private company to reach out directly to the public for support

The lung cancer breath test developer is enabling investors to buy US$3 shares through a Reg CF financing

The institute is looking to implement a marriage between robotic bronchoscopy and advanced imaging technology

The integration of AI into routine imaging processes has proven to be a cost-effective triaging tool

The buyer is offering a significant premium to acquire Regulus

Japan's venture capital firm X&KSK led the Series C round

The U.S. Food and Drug Administration (FDA) granted cretostimogene Fast Track and Breakthrough Therapy designations

China's National Medical Products Administration approved the initial new drug application in January

The Swiss company's Optune Lua device received FDA approval last fall

The company has developed an antibody to fight against a protein that makes lung cancer cells resistant to drugs

University of California researchers have determined that these machines can cause 1 out of every 20 new cancer cases

The company has received support from the Centre of Expertise in Advanced Materials and Sustainability and Innovate UK

It correctly identified positive cases with 80 to 92% accuracy

Lung cancer remains the leading cause of cancer death in the United States

The newly announced partnership sent shares up by 137% at the intraday peak on the Nasdaq Tuesday

It will get phased in within the next 2 years

The Worker Health Protection Program's screening initiative has helped catch cases linked to radiation exposure in their early stages

The company has met a key requirement for regulatory submissions in the US and Europe

Relacorilant is designed to address disorders linked to the stress hormone cortisol

The disease can often be eliminated through surgery or targeted radiation in its early stages

This approval is a hard-won victory for Soleno after a lengthy clinical trial phase

It uses a machine with 70 sensors to detect volatile organic compounds associated with the disease

This therapeutic is specifically designed for suicidal depression

Thankfully, early detection and treatment measures are bringing hope to people who receive the unfortunate news

Individual biotech stocks often decouple from macro trends when company developments or investor enthusiasm take center stage

More than 480 residents participated in the American Lung Association's annual event

The deal could provide shareholders with an extra $0.70 per share if company's drug gains regulatory approval in Europe

It features the state's first AI-powered lung nodule detection program

"A truly MONUMENTAL day," said a representative from the IU Simon Comprehensive Cancer Center

Taletrectinib is the most advanced drug in the company's pipeline

The company's product for relapsing forms of multiple sclerosis (RMS), is its primary source of its most recent success